Novanta (NOVT) Projected to Post Earnings on Monday

Key Points

• Novanta will report Q1 2026 results before the market opens on Monday, May 11; analysts expect $0.77 EPS and $253.4M revenue, and the company has guided FY2026 EPS of 3.50–3.65 and Q1 EPS of 0.75–0.80 (conference call on May 12 at 8:00 AM ET).
• Corporate insiders have been net sellers recently — the CEO and CFO sold shares this year, with insiders offloading 25,380 shares worth about $3.30M over the last 90 days, leaving insiders owning roughly 1.2% of the company.
• The stock trades with a market cap of $4.55B and a P/E of ~87.6, and analysts' consensus rating is a Hold with an average target price of $144.00.

Novanta (NASDAQ:NOVT - Get Free Report) is expected to post its Q1 2026 results before the market opens on Monday, May 11th. Analysts expect Novanta to post earnings of $0.77 per share and revenue of $253.3990 million for the quarter. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q1 2026 guidance at 0.750-0.800 EPS. Individuals can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Tuesday, May 12, 2026 at 8:00 AM ET.

Novanta (NASDAQ:NOVT - Get Free Report) last announced its quarterly earnings data on Monday, February 23rd. The technology company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.88 by $0.03. The firm had revenue of $258.35 million during the quarter, compared to analysts' expectations of $260.72 million. Novanta had a return on equity of 13.12% and a net margin of 5.49%.During the same period in the previous year, the business posted $0.76 EPS. On average, analysts expect Novanta to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Stock Performance

Shares of NASDAQ:NOVT opened at $127.87 on Monday. The stock has a market capitalization of $4.55 billion, a P/E ratio of 87.58 and a beta of 1.62. Novanta has a 1-year low of $98.27 and a 1-year high of $149.95. The business has a 50-day moving average price of $126.19 and a two-hundred day moving average price of $124.42. The company has a current ratio of 3.69, a quick ratio of 2.80 and a debt-to-equity ratio of 0.16.

Insider Activity

In related news, CEO Matthijs Glastra sold 7,500 shares of the business's stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $145.04, for a total value of $1,087,800.00. Following the completion of the transaction, the chief executive officer directly owned 57,367 shares in the company, valued at approximately $8,320,509.68. The trade was a 11.56% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Robert Buckley sold 9,957 shares of the business's stock in a transaction that occurred on Monday, March 16th. The shares were sold at an average price of $116.77, for a total value of $1,162,678.89. Following the completion of the transaction, the chief financial officer owned 96,616 shares of the company's stock, valued at $11,281,850.32. This represents a 9.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 25,380 shares of company stock valued at $3,296,276 over the last 90 days. Corporate insiders own 1.20% of the company's stock.

Hedge Funds Weigh In On Novanta

Institutional investors and hedge funds have recently modified their holdings of the business. Entropy Technologies LP grew its position in shares of Novanta by 33.8% in the 3rd quarter. Entropy Technologies LP now owns 4,748 shares of the technology company's stock valued at $476,000 after purchasing an additional 1,200 shares during the period. Quadrant Capital Group LLC grew its position in shares of Novanta by 1,550.5% in the 4th quarter. Quadrant Capital Group LLC now owns 3,598 shares of the technology company's stock valued at $428,000 after purchasing an additional 3,380 shares during the period. Nicolet Advisory Services LLC grew its position in shares of Novanta by 7.1% in the 3rd quarter. Nicolet Advisory Services LLC now owns 4,046 shares of the technology company's stock valued at $409,000 after purchasing an additional 269 shares during the period. Toronto Dominion Bank grew its position in shares of Novanta by 32.7% in the 4th quarter. Toronto Dominion Bank now owns 3,382 shares of the technology company's stock valued at $402,000 after purchasing an additional 834 shares during the period. Finally, CIBC Bancorp USA Inc. acquired a new position in shares of Novanta in the 3rd quarter valued at approximately $386,000. 98.35% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on NOVT shares. Weiss Ratings restated a "hold (c-)" rating on shares of Novanta in a research report on Friday, April 17th. Zacks Research upgraded Novanta from a "strong sell" rating to a "hold" rating in a research report on Friday, January 16th. Robert W. Baird upgraded Novanta from a "neutral" rating to an "outperform" rating and decreased their target price for the stock from $150.00 to $144.00 in a research report on Monday, March 30th. Finally, Wall Street Zen lowered Novanta from a "buy" rating to a "hold" rating in a research report on Saturday, April 18th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the company's stock. According to data from MarketBeat, Novanta presently has an average rating of "Hold" and an average target price of $144.00.

Novanta Company Profile

Novanta, Inc NASDAQ: NOVT is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta's product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta's Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.